Clinical trial
An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR…
NCT00449111 · Organon and Co, Industry · Terminated
Key facts
| NCT number | NCT00449111 |
|---|---|
| Title | An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hypertension (0954A-325) |
| Official title | An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hypertension |
| Lead sponsor | Organon and Co, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | MK0954, losartan potassium / Duration of Treatment - 12 weeks |
| Enrollment | 11 |
| Start date | Mar 13, 2006 |
| Primary completion | Sep 30, 2006 |
| Completion | Sep 30, 2006 |
| First posted | Mar 19, 2007 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: